AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment

Clinical trial NCT07203885 · COMPLETED

Trial details

NCT number: NCT07203885
Sponsor: Harvard Medical School (HMS and HSDM)
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Promyelocytic Leukemia (APL)Acute Myeloid Leukaemia (AML)

Start date: 2025-09-09
Primary completion: 2025-10-10
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.